Business EconomyPosted at: Nov 12 2025 5:19PM


Gold likely to surge $4,600 per ounce amid central bank demand, weakening dollar

New Delhi, Nov 12 (UNI) Gold remains on solid technical footing, with upside targets pegged at USD4,368 and USD 4,600 per ounce, while support levels exist around USD 3,890 to 3,510, according to Emkay Wealth Management.
Recently, gold touched USD 4,368 in October before a modest pullback to just under USD 4,000 by month-end, driven by a 1.4 pc appreciation in the US dollar over the past month.
Analysts at Emkay Wealth Management believe that the longer-term trend for gold remains upward, supported by sustained institutional and central bank demand and a weakening dollar environment over the past year.
The geopolitical issues that have persisted in eastern Europe and West Asia have led investors to seek safety in gold. "The US dollar's 8pc depreciation over the past year has also supported a broad rally in commodities, including precious metals."
According to Emkay, year-to-date inflows stand at USD65 billion, with nearly USD 20 billion added in the last three months alone. Central banks have been key participants in this trend, diversifying their reserves away from dollar-denominated assets amid mounting global macroeconomic uncertainty.
Emkay Wealth's analysis suggests gold could continue consolidating near the USD 4,000 mark before attempting another move higher.
The firm's upside resistance targets of USD 4,368 to 4,600 represent potential breakout points, while downside supports at USD3,890 -3,510 are seen as accumulation zones for long-term investors.
The advisory recommends that investors "hold existing positions and add on dips", viewing current price corrections as an opportunity rather than a threat.
"Gold's long-term structure remains intact, supported by continued institutional buying, diversification away from the dollar, and resilient consumer demand," it said.
UNI VK SAS PRS
Please log in to get detailed story.
Tags: #Gold likely to surge $4#600 per ounce amid central bank demand# weakening dollar
More News

Brookfield, FedEx to set up GCCs in Mumbai

14 Dec 2025 | 1:39 AM

Mumbai, Dec 13 (UNI) Global alternative asset management and investment firm, Brookfield as well as FedEx Corporation plan to set up Asia’s largest global capability centre (GCC) in Mumbai, Maharashtra Chief Minister Devendra Fadnavis has announced.

see more..

Kerala boasts cost-effective ecosystem of space vendors: Experts at Huddle Global 2025

14 Dec 2025 | 1:02 AM

Thiruvananthapuram, Dec 13 (UNI) Kerala has a very cost-effective and mature ecosystem of space vendors that would help the country become a global vendor in the sector, said experts today at Huddle Global 2025.

see more..

AP: Ponduru Khadi from Srikakulam receives prestigious GI Tag

13 Dec 2025 | 8:22 PM

Srikakulam, (Andhra Pradesh), Dec 13 (UNI) After years of sustained efforts involving extensive documentation, meetings, and follow-ups, Ponduru Khadi, a traditional handwoven fabric from Srikakulam district, has been awarded the prestigious Geographical Indication (GI) tag, union Civil Aviation Minister Kinjarapu Ram Mohan Naidu on Saturday.
Ram Mohan Naidu, also a native of Srikakulam, expressed immense pride over the achievement.

see more..

SBI report flags marginal rise in inflation but sees comfort on prices and rates

13 Dec 2025 | 2:37 PM

New Delhi, Dec 13 (UNI) India’s retail inflation has shown a marginal reversal in November 2025 but remains at a comfortable level, with overall price pressures still muted, according to SBI Research’s latest Ecowrap report released on Saturday here.

see more..

Ozempic ® - world’s most prescribed GLP-1is now available in India

13 Dec 2025 | 4:02 AM

Hyderabad, Dec 12 (UNI) Novo Nordisk, a global healthcare company, on Friday announced the launch of its once-weekly diabetes drug Ozempic® (injectable semaglutide) in India, marking a significant addition to the country’s treatment options for type 2 diabetes.
The therapy, a GLP-1 receptor agonist, is approved as an adjunct to diet and exercise for adults with uncontrolled type 2 diabetes mellitus (T2DM).

see more..